Kathy Robinson

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules

Gerard A. Silvestri, Nichole T. Tanner, Paul Kearney et al. · CHEST Journal · 2018 · 163 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation

Oliver Tiebel, Kazuhiro Oka, Kathy Robinson et al. · Atherosclerosis · 1999 · 74 citations

Life Sciences, Biochemistry, Molecular Biology +16

Renal cell tumors convert natural killer cells to a proangiogenic phenotype

Yue Guan, Christopher B. Chambers, Taylor Tabatabai et al. · Oncotarget · 2020 · 38 citations · Full text

Medicine, Immunology, Oncology +12

Immune Characterization of the Programmed Death Receptor Pathway in High Risk Prostate Cancer

Wesley Baas, Svetlana Gershburg, Danuta Dynda et al. · Clinical Genitourinary Cancer · 2017 · 35 citations

Life Sciences, Immunology, Oncology +16

Phase I trial of intravesical Bacillus Calmette–Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette–Guérin treatment

Shaheen Alanee, Sherjeel Sana, Ahmed El‐Zawahry et al. · World Journal of Urology · 2021 · 27 citations

Medicine, Oncology, Urology +15